Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer

Colloids and Surfaces B: Biointerfaces

Volumn 106, Issue , 2013, Pages 117-125

  Heidari Majd, Mostafa ^a,b   Asgari, Davoud ^a,b   Barar, Jaleh ^a,b,c   Valizadeh, Hadi ^a,b   Kafil, Vala ^a,b   Abadpour, Alaleh ^b   Moumivand, Efat ^a   Mojarrad, Javid Shahbazi ^a,b   Rashidi, Mohammad Reza ^a,b   Coukos, George ^c   Omidi, Yadollah ^a,b,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer; Folate receptor; Magnetic nanoparticles; Nanomedicine; Tamoxifen

Indexed keywords

3-AMINOPROPYLTRIETHOXYSILANE; AMINO GROUP; AVERAGE SIZE; BI-FUNCTIONAL; CANCER; CANCER CELLS; CONTRAST AGENT; ETHYLENE DIAMINE; FLOW CYTOMETRY ANALYSIS; FOLATE RECEPTOR; FOLIC ACIDS; GROWTH INHIBITION; HUMAN BREAST CANCER; LATTER COMPLEXES; LOADING EFFICIENCY; MAGNETIC NANO-PARTICLES; MAGNETIC NANOPARTI CLES (MNPS); MCF-7 CELLS; NANOMEDICINES; NANOPARTICLE (NPS); PEGYLATED; POLYETHYLENE GLYCOL (PEG); SIMULTANEOUS IMAGING; TAMOXIFEN; TARGETED IMAGING; TRIETHOXYSILANE;

CELLS; CHLORINE COMPOUNDS; DECOMPOSITION; DISEASES; DRUG DELIVERY; ETHYLENE; FLOW CYTOMETRY; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; SILANES;

SYNTHESIS (CHEMICAL);

3 AMINOPROPYLTRIETHOXYSILANE; ETHYLENEDIAMINE; FOLATE RECEPTOR; FOLIC ACID; MACROGOL; TAMOXIFEN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CANCER CELL CULTURE; COMPLEX FORMATION; CONCENTRATION RESPONSE; DECOMPOSITION; DRUG CYTOTOXICITY; DRUG DELIVERY DEVICE; DRUG EFFECT; DRUG TARGETING; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR IMAGING; MOLECULAR INTERACTION; NANOENCAPSULATION; NANOPHARMACEUTICS; PARTICLE SIZE; PRIORITY JOURNAL; TIMED DRUG RELEASE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLOW CYTOMETRY; FOLIC ACID; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; POLYETHYLENE GLYCOLS; TAMOXIFEN;

EID: 84874544178     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.01.051     Document Type: Article

References (61)

1. Lee N., Hyeon T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem. Soc. Rev. 2012, 41:2575-2589.
2. Bu L., Xie J., Chen K., Huang J., Aguilar Z.P., Wang A., Sun K.W., Chua M.S., So S., Cheng Z., Eden H.S., Shen B., Chen X. Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma. Contrast Media Mol. Imaging 2012, 7:363-372.
3. Corr S.A., Byrne S.J., Tekoriute R., Meledandri C.J., Brougham D.F., Lynch M., Kerskens C., O'Dwyer L., Gun'ko Y.K. Linear assemblies of magnetic nanoparticles as MRI contrast agents. J. Am. Chem. Soc. 2008, 130:4214-4215.
4. Yigit M.V., Moore A., Medarova Z. Magnetic nanoparticles for cancer diagnosis and therapy. Pharm. Res. 2012, 29:1180-1188.
5. Tietze R., Lyer S., Durr S., Alexiou C. Nanoparticles for cancer therapy using magnetic forces. Nanomedicine (Lond.) 2012, 7:447-457.
6. Li C., Li L., Keates A.C. Targeting cancer gene therapy with magnetic nanoparticles. Oncotarget 2012, 3:365-370.
7. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5:161-171.
8. Zhou J., Wu W., Caruntu D., Yu M.H., Martin A., Chen J.F., O'Connor C.J., Zhou W.L. Synthesis of porous magnetic hollow silica nanospheres for nanomedicine application. J. Phys. Chem. C 2007, 111:17473-17477.
9. Robinson I., Tung L.D., Maenosono S., Walti C., Thanh N.T.K. Synthesis of core-shell gold coated magnetic nanoparticles and their interaction with thiolated DNA. Nanoscale 2010, 2:2624-2630.
10. Kohler N., Fryxell G.E., Zhang M. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J. Am. Chem. Soc. 2004, 126:7206-7211.
11. Bae K.H., Kim Y.B., Lee Y., Hwang J., Park H., Park T.G. Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast T1- and T2-weighted magnetic resonance imaging. Bioconjug. Chem. 2010, 21:505-512.
12. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
13. 4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv. Mater. 2007, 19:3163-3166.
14. Yoo H.S., Park T.G. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J. Control. Release 2004, 100:247-256.
15. Qi L., Wu L., Zheng S., Fu H., Cui D., Wang Y. Cell penetrating magnetic nanoparticles for high efficient delivery and intracellular imaging of siRNA. Biomacromolecules 2012, 13:2723-2730.
16. Maeng J.H., Lee D.H., Jung K.H., Bae Y.H., Park I.S., Jeong S., Jeon Y.S., Shim C.K., Kim W., Kim J., Lee J., Lee Y.M., Kim J.H., Kim W.H., Hong S.S. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials 2010, 31:4995-5006.
17. Kohler N., Sun C., Wang J., Zhang M. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir 2005, 21:8858-8864.
18. Lee J.H., Lee K., Moon S.H., Lee Y., Park T.G., Cheon J. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew. Chem. Int. Ed. Engl. 2009, 48:4174-4179.
19. Adolphi N.L., Butler K.S., Lovato D.M., Tessier T.E., Trujillo J.E., Hathaway H.J., Fegan D.L., Monson T.C., Stevens T.E., Huber D.L., Ramu J., Milne M.L., Altobelli S.A., Bryant H.C., Larson R.S., Flynn E.R. Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI. Contrast Media Mol. Imaging 2012, 7:308-319.
20. Choi H., Choi S.R., Zhou R., Kung H.F., Chen I.W. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad. Radiol. 2004, 11:996-1004.
21. Fang C., Veiseh O., Kievit F., Bhattarai N., Wang F., Stephen Z., Li C., Lee D., Ellenbogen R.G., Zhang M. Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties and in vivo behavior. Nanomedicine (Lond.) 2010, 5:1357-1369.
22. Kelemen L.E. The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?. Int. J. Cancer 2006, 119:243-250.
23. Low P.S., Antony A.C. Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv. Drug Deliv. Rev. 2004, 56:1055-1058.
24. Hu F.X., Neoh K.G., Kang E.T. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials 2006, 27:5725-5733.
25. Kim S.Y., Lee Y.M. Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers. Biomaterials 2001, 22:1697-1704.
26. Harper M.J., Walpole A.L. A new derivative of triphenylethylene: effect on implantation and mode of action in rats. J. Reprod. Fertil. 1967, 13:101-119.
27. Perez E., Benito M., Teijon C., Olmo R., Teijon J.M., Blanco M.D. Tamoxifen-loaded nanoparticles based on a novel mixture of biodegradable polyesters: characterization and in vitro evaluation as sustained release systems. J. Microencapsul. 2012, 29:309-322.
28. Blanco M.D., Guerrero S., Benito M., Teijon C., Olmo R., Muniz E., Katime I., Teijon J.M. Tamoxifen-loaded folate-conjugate poly[(p-nitrophenyl acrylate)-co-(N-isopropylacrylamide)] sub-microgel as antitumoral drug delivery system. J. Biomed. Mater. Res. A 2010, 95:1028-1040.
29. Hu F., Neoh K.G., Kang E.T. Synthesis of folic acid functionalized PLLA-b-PPEGMA nanoparticles for cancer cell targeting. Macromol. Rapid Commun. 2009, 30:609-614.
30. 4 nanoparticles. J. Am. Chem. Soc. 2008, 130:14436-14437.
31. Zhang J., Rana S., Srivastava R.S., Misra R.D. On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles. Acta Biomater. 2008, 4:40-48.
32. Moros M., Pelaz B., Lopez-Larrubia P., Garcia-Martin M.L., Grazu V., de la Fuente J.M. Engineering biofunctional magnetic nanoparticles for biotechnological applications. Nanoscale 2010, 2:1746-1755.
33. Sonvico F., Mornet S., Vasseur S., Dubernet C., Jaillard D., Degrouard J., Hoebeke J., Duguet E., Colombo P., Couvreur P. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug. Chem. 2005, 16:1181-1188.
34. Aurelio L., Figler H., Flynn B.L., Linden J., Scammells P.J. 5-Substituted 2-aminothiophenes as A1 adenosine receptor allosteric enhancers. Bioorg. Med. Chem. 2008, 16:1319-1327.
35. Li M., Selvin P.R. Amine-reactive forms of a luminescent diethylenetriaminepentaacetic acid chelate of terbium and europium: attachment to DNA and energy transfer measurements. Bioconjug. Chem. 1997, 8:127-132.
36. Moogooee M., Ramezanzadeh H., Jasoori S., Omidi Y., Davaran S. Synthesis and in vitro studies of cross-linked hydrogel nanoparticles containing amoxicillin. J. Pharm. Sci. 2011, 100:1057-1066.
37. Mooguee M., Omidi Y., Davaran S. Synthesis and in vitro release of adriamycin from star-shaped poly(lactide-co-glycolide) nano- and microparticles. J. Pharm. Sci. 2010, 99:3389-3397.
38. Hou Y., Xu Z., Sun S. Controlled synthesis and chemical conversions of FeO nanoparticles. Angew. Chem. 2007, 119:6445-6448.
39. Barzegar-Jalali M., Adibkia K., Valizadeh H., Shadbad M.R., Nokhodchi A., Omidi Y., Mohammadi G., Nezhadi S.H., Hasan M. Kinetic analysis of drug release from nanoparticles. J. Pharm. Pharm. Sci. 2008, 11:167-177.
40. Kafil V., Omidi Y. Cytotoxic impacts of linear and branched polyethylenimine nanostructures in A431 cells. Bioimpacts 2011, 1:23-30.
41. Omidi Y., Barar J. Induction of human alveolar epithelial cell growth factor receptors by dendrimeric nanostructures. Int. J. Toxicol. 2009, 28:113-122.
42. Omidi Y., Hollins A.J., Benboubetra M., Drayton R., Benter I.F., Akhtar S. Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells. J. Drug Target. 2003, 11:311-323.
43. Nakhlband A., Barar J., Bidmeshkipour A., Heidari H.R., Omidi Y. Bioimpacts of anti epidermal growth factor receptor antisense complexed with polyamidoamine dendrimers in human lung epithelial adenocarcinoma cells. J. Biomed. Nanotechnol. 2010, 6:360-369.
44. Xu Z., Shen C., Hou Y., Gao H., Sun S. Oleylamine as both reducing agent and stabilizer in a facile synthesis of magnetite nanoparticles. Chem. Mater. 2009, 21:1778-1780.
45. Kang S.M., Choi I.S., Lee K.B., Kim Y. Bioconjugation of poly(poly(ethylene glycol) methacrylate)-coated iron oxide magnetic nanoparticles for magnetic capture of target proteins. Macromol. Res. 2009, 17:259-264.
46. Omidi Y. Smart multifunctional theranostics: simultaneous diagnosis and therapy of cancer. Bioimpacts 2011, 1:145-147.
47. Omidi Y. Translational researches require effective protocols for knowledge and technology transfer and integration. Bioimpacts 2011, 1:71-73.
48. Barar J., Omidi Y. Translational approaches towards cancer gene therapy: hurdles and hopes. Bioimpacts 2012, 2:127-143.
49. Wu S.H., Lin C.Y., Hung Y., Chen W., Chang C., Mou C.Y. PEGylated silica nanoparticles encapsulating multiple magnetite nanocrystals for high-performance microscopic magnetic resonance angiography. J. Biomed. Mater. Res. B: Appl. Biomater. 2011, 99:81-88.
50. Gautier J., Munnier E., Paillard A., Herve K., Douziech-Eyrolles L., Souce M., Dubois P., Chourpa I. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting. Int. J. Pharm. 2012, 423:16-25.
51. Kumagai M., Sarma T.K., Cabral H., Kaida S., Sekino M., Herlambang N., Osada K., Kano M.R., Nishiyama N., Kataoka K. Enhanced in vivo magnetic resonance imaging of tumors by PEGylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties. Macromol. Rapid Commun. 2010, 31:1521-1528.
52. Larsen E.K., Nielsen T., Wittenborn T., Birkedal H., Vorup-Jensen T., Jakobsen M.H., Ostergaard L., Horsman M.R., Besenbacher F., Howard K.A., Kjems J. Size-dependent accumulation of PEGylated silane-coated magnetic iron oxide nanoparticles in murine tumors. ACS Nano 2009, 3:1947-1951.
53. Zhang Y., Kohler N., Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002, 23:1553-1561.
54. Hathaway H.J., Butler K.S., Adolphi N.L., Lovato D.M., Belfon R., Fegan D., Monson T.C., Trujillo J.E., Tessier T.E., Bryant H.C., Huber D.L., Larson R.S., Flynn E.R. Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors. Breast Cancer Res. 2011, 13:R108.
55. Cole A.J., Yang V.C., David A.E. Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol. 2011, 29:323-332.
56. M. Heidari Majd, D. Asgari, J. Barar, H. Valizadeh, V. Kafil, G. Coukos, Y. Omidi, Specific targeting of cancer cells by multifunctional mitoxantrone conjugated magnetic nanoparticles, J. Drug Target. , in progress. doi:10.3109/1061186X.2012.750325.
57. Yu F.L., Bender W. A proposed mechanism of tamoxifen in breast cancer prevention. Cancer Detect. Prev. 2002, 26:370-375.
58. Khalkhali-Ellis Z., Christian A.L., Kirschmann D.A., Edwards E.M., Rezaie-Thompson M., Vasef M.A., Gruman L.M., Seftor R.E., Norwood L.E., Hendrix M.J. Regulating the tumor suppressor gene maspin in breast cancer cells: a potential mechanism for the anticancer properties of tamoxifen. Clin. Cancer Res. 2004, 10:449-454.
59. Yasue A., Hasegawa K., Udagawa Y. Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity. Hum. Cell 2011, 24:65-73.
60. Li Z., Kawashita M., Araki N., Mitsumori M., Hiraoka M., Doi M. Preparation of magnetic iron oxide nanoparticles for hyperthermia of cancer in a FeCl(2)-NaNO(3)-NaOH aqueous system. J. Biomater. Appl. 2011, 25:643-661.
61. Wankhede M., Bouras A., Kaluzova M., Hadjipanayis C.G. Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Expert Rev. Clin. Pharmacol. 2012, 5:173-186.